ORTEXORTEX News
Tracking VTR? Get live short interest, options flow, and signals on ORTEX.Sign up free →
VT
Earnings PreviewVTR

Ventas Shorts Reverse Course as Q3 Results Land

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 28 Oct 2026, 04:01

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

VTR short sellers added positions sharply in the final days before the Q3 print, reversing a monthlong retreat that had cut the short book nearly in half.

Short interest rose 18% in a single session on October 26 and is up 15% on the week, bringing the total borrowed position to 14.2 million shares, or 3.0% of the free float. That is still well below the late-September peak of around 23 million shares, when the short position sat above 4.5% of float. The rebuild is modest in absolute terms, but the speed of the reversal is notable. Borrow costs remain negligible at 0.44%, and availability runs at 4,335%: for every share currently borrowed, more than 43 remain available in the lending pool. There is no squeeze pressure at these levels.

The stock fell 4.7% on October 27 to close at $83.34, leaving it down 3.6% on the week. That is a steeper move than most close peers: WELL dropped 4.8% on the day and AHR fell 4.6%, while OHI and SBRA lost less than 2% and are roughly flat on the week. The sector-wide selling hit the larger, more rate-sensitive names hardest.

Analyst targets have been moving in one direction. Wells Fargo cut from $104 to $96 on October 19 while keeping an Overweight rating. Barclays trimmed from $102 to $91 on October 13, maintaining Equal-Weight. The consensus mean price target of $100.50 implies roughly 21% upside from Tuesday's close, but that gap has widened partly because the stock has fallen rather than because targets have risen. The bull case rests on senior housing operating momentum: same-store NOI grew 15.4% in Q1 2026, and the balance sheet has tightened to net debt to EBITDA of 5.0x. The bear case centres on acquisition pace: management raised investment guidance to $4.5 billion after deploying $3.2 billion year-to-date, at a point when cap rates are expected to compress further toward 6.0% by 2028, leaving less room for accretion. JP Morgan Asset Management added 7.2 million shares in the quarter to September 30, bringing its stake to 7.5% of shares outstanding, the largest single move among the top institutional holders in the period.

The Q3 print will test whether the SHOP operating momentum that drove the first half of 2026 has held through the summer months, and whether the pace of capital deployment is generating the returns the investment guidance implies.

Stocks in this article

See the live data behind this article on ORTEX.

Open VTR on ORTEX →

How this article was generated

Generated
28 Oct 2026, 04:10
Data as of
28 Oct 2026, 04:01
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.